32

BrainStorm

January 17, 2023

George Vradenburg and the Future of Alzheimer's Advocacy - Part 1

George Vradenburg and the Future of Alzheimer's Advocacy - Part 1

About This Episode

The Food and Drug Administration expedited approval of Lecanemab, a drug developed by Eisai and Biogen, that demonstrated positive results in slowing Alzheimer's disease. What does this mean for the future of Alzheimer’s advocacy?

In this episode of BrainStorm, host Meryl Comer talks with George Vradenburg, Chairman and Co-Founder of UsAgainstAlzheimer’s, Convener of Global CEOi and Co-Convener with the World Economic Forum of the Davos Alzheimer’s Collaborative.  They discuss the immediate implications of the drug approval, how it will impact the Alzheimer’s movement, and what it means for the future of Alzheimer’s disease. 

Do you have feedback or an idea for the podcast? Send us a note at BrainStorm@usagainstalzheimers.org.
 

Support the show

BrainStorm Feed

31
December 20, 2022 | 14:40

Ken Dychtwald - Breakthroughs at the Tipping Point

Rising longevity and the aging of boomers worldwide are radically altering both the demographic landscape and every aspect of our personal, social,

LISTEN NOW
30
December 6, 2022 | 13:28

Dr. Larry Cahill – The Differences Between Female and Male Brains – part 2

Your brain controls and coordinates everything your body does from the movement of your fingers to your heart rate.

LISTEN NOW
29
November 15, 2022 | 12:27

Dr. Larry Cahill - The Differences Between Female and Male Brains - part 1

Just as the bodies of men and women are different, so are their brains.
LISTEN NOW